Testing for Early Diagnosis of Alzheimer’s Disease

Alireza Atri, MD, PhD, describes the pathophysiology of Alzheimer’s disease (AD).

Dr Atri lists the common screening tools used to form an AD diagnosis.

An expert explains the role biomarker testing plays when diagnosing a patient with AD.

Alireza Atri, MD, PhD, discusses aducanumab’s recent FDA approval for the treatment of AD.

Dr Atri explains how aducanumab plays a role in diagnostic evaluations for patients with AD.

Dr Atri continues his discussion on aducanumab and AD diagnostic evaluations.

Alireza Atri, MD, PhD, concludes with a discussion on how different testing methods impact the care of patients with AD.